TY - JOUR
T1 - HUGO(TM) RAS System in urogynaecology: the first nerve sparing Sacral Colpopexy for Pelvic Organ Prolapse
AU - Panico, Giovanni
AU - Campagna, Giuseppe
AU - Caramazza, Daniela
AU - Vacca, L
AU - Mastrovito, Sara
AU - Ercoli, Alfredo
AU - Scambia, Giovanni
PY - 2023
Y1 - 2023
N2 - Background: Minimally invasive sacral colpopexy is considered the gold standard for surgical treatment of Pelvic Organ Prolapse (POP), combining high success rates with low recurrence risk in comparison to other techniques. This is the first case of robotic sacral colpopexy (RSCP) performed with the innovative HugoTM RAS robotic system. Objectives: The aim of this article is to show the surgical steps of a nerve sparing RSCP performed with the new HugoTM RAS robotic system (Medtronic), by also evaluating the feasibility of this technique using this novel Robotic System.Materials and methods: A 50-year-old Caucasian woman with symptomatic pelvic organ prolapse (POP-Q): Aa: +2, Ba: +3, C: +4, D: +4, Bp:-2, Ap:-2 , TVL:10 GH: 3,5 BP:3 underwent RSCP as well as a subtotal hysterectomy with bilateral salpingo-oophorectomy, using the new surgical robot HugoTM RAS in the Division of Urogynaecology and Pelvic Reconstructive Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Main outcome measures: Intraoperative data, docking specifics, objective and subjective outcomes at three months follow up.Results: Surgical procedure was carried out without intra-operative complications, operative time (OT) was 150 minutes, docking time was 9 minutes. No system errors or faults in the robotic arms were registered. Urogynaecological examination at three months follow up showed a complete resolution of the prolapse.Conclusion: RSCP using the HugoTM RAS system seems to be a feasible and effective approach according to results in terms of operative time, cosmetic results, postoperative pain and length of hospitalisation. Large number of case reports as well as longer follow up are mandatory to better define its benefits, advantages, and costs.
AB - Background: Minimally invasive sacral colpopexy is considered the gold standard for surgical treatment of Pelvic Organ Prolapse (POP), combining high success rates with low recurrence risk in comparison to other techniques. This is the first case of robotic sacral colpopexy (RSCP) performed with the innovative HugoTM RAS robotic system. Objectives: The aim of this article is to show the surgical steps of a nerve sparing RSCP performed with the new HugoTM RAS robotic system (Medtronic), by also evaluating the feasibility of this technique using this novel Robotic System.Materials and methods: A 50-year-old Caucasian woman with symptomatic pelvic organ prolapse (POP-Q): Aa: +2, Ba: +3, C: +4, D: +4, Bp:-2, Ap:-2 , TVL:10 GH: 3,5 BP:3 underwent RSCP as well as a subtotal hysterectomy with bilateral salpingo-oophorectomy, using the new surgical robot HugoTM RAS in the Division of Urogynaecology and Pelvic Reconstructive Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Main outcome measures: Intraoperative data, docking specifics, objective and subjective outcomes at three months follow up.Results: Surgical procedure was carried out without intra-operative complications, operative time (OT) was 150 minutes, docking time was 9 minutes. No system errors or faults in the robotic arms were registered. Urogynaecological examination at three months follow up showed a complete resolution of the prolapse.Conclusion: RSCP using the HugoTM RAS system seems to be a feasible and effective approach according to results in terms of operative time, cosmetic results, postoperative pain and length of hospitalisation. Large number of case reports as well as longer follow up are mandatory to better define its benefits, advantages, and costs.
KW - Laparoscopy
KW - pelvic organ prolapse
KW - dissection
KW - anatomy
KW - colposacropexy
KW - Laparoscopy
KW - pelvic organ prolapse
KW - dissection
KW - anatomy
KW - colposacropexy
UR - http://hdl.handle.net/10807/283496
U2 - 10.52054/FVVO.15.1.054
DO - 10.52054/FVVO.15.1.054
M3 - Article
SN - 2032-0418
VL - 15
SP - 83
EP - 87
JO - FACTS, VIEWS & VISION IN OBGYN
JF - FACTS, VIEWS & VISION IN OBGYN
ER -